Monash IVF Group Ltd (DE:MIS)
FRANKFURT:MIS
MIS Stock Chart & Stats
€0.44
>-€0.01(-0.68%)
At close: 4:00 PM EST
€0.44
>-€0.01(-0.68%)
Day’s Range― - ―
52-Week Range€0.29 - €0.48
Previous CloseN/A
Volume0.00
Average Volume (3M)349.00
Market Cap
€165.58M
Enterprise Value€558.45M
Total Cash (Recent Filing)€8.14M
Total Debt (Recent Filing)€281.81M
Price to Earnings (P/E)17.9
Beta1.00
Next Earnings
Aug 24, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding389,634,830
10 Day Avg. Volume805
30 Day Avg. Volume349
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.12
Price to Sales (P/S)1.01
P/FCF Ratio588.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.52Price Target Upside19.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)0.03
Revenue Forecast (FY)€164.18M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA 74.5% year increase indicates durable expansion in service volumes or pricing power across clinics. Sustained top-line growth supports reinvestment in clinics and labs, enhances scale economics in embryology services, and underpins multi-quarter revenue visibility for core fertility services.
Profitability & MarginsSolid gross and net margins reflect profitable service delivery and an ability to cover clinical and lab costs. Margin levels support internal capital allocation to technology, staffing and potential clinic expansion, making earnings generation more resilient to modest demand swings over months.
Balance Sheet HealthA moderate leverage profile and stable equity ratio provide financial flexibility for capex or acquisitions without overstretching liquidity. ROE around 10% signals efficient use of shareholder capital, supporting sustainable investment in clinics and specialist staffing over the medium term.
Bears Say
Weak Free Cash Flow ConversionA near-100% drop in free cash flow and low OCF/net income ratio indicate earnings are not being reliably converted to cash. This impairs capacity to fund dividends, service debt or invest without external funding, reducing financial resilience over the coming quarters.
Margin VolatilityFluctuating EBIT/EBITDA margins suggest operating leverage tied to treatment volumes and cost base. Persistent volatility complicates forecasting and capital allocation, increasing execution risk for multi-quarter plans like clinic rollouts or staffing investments.
Volume-dependent RevenueRevenue sensitivity to cycle volumes and service mix exposes performance to demographic trends, patient demand shifts, and reimbursement changes. Over the medium term, this structural dependence can produce revenue variability and pressure margins if volumes soften or case mix shifts unfavorably.
Monash IVF Group Ltd News
MIS FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest stock price was €0.29 and its highest was €0.48 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is €165.58M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Aug 24, 2026 which is in 76 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Monash IVF Group Ltd released its earnings results on Feb 25, 2026. The company reported €0.011 earnings per share for the quarter, missing the consensus estimate of €0.015 by -€0.004.
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd does not currently pay dividends.
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate is 0.02.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Monash IVF Group Ltd reported an EPS of €0.011 in its last earnings report, missing expectations of €0.015. Following the earnings report the stock price went down -0.508%.
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in DE:MIS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€0.52 (19.26% Upside)
€0.52 (19.26% Upside)
Blogger Sentiment
Bullish
DE:MIS Sentiment 94%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.39%
12-Months-Change
Fundamentals
Return on Equity
6.06%
Trailing 12-Months
Asset Growth
0.49%
Trailing 12-Months
Company Description
Monash IVF Group Ltd
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
MIS Stock 12 Month Forecast
Average Price Target
€0.52
▲(19.26% Upside)
Technical Analysis
Healius Limited
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---